Ligand validation:6E1X

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6E1X_MRD_C_204	59%	83%	0.097	0.876	0.21	0.56	-	-	0	0	100%	1
6E1X_MRD_D_203	51%	87%	0.119	0.87	0.22	0.48	-	-	0	0	100%	1
6E1X_MRD_C_205	49%	67%	0.153	0.9	0.4	0.85	-	-	0	0	100%	1
6E1X_MRD_D_204	40%	69%	0.149	0.86	0.47	0.73	-	-	0	0	100%	0.8
6E1X_MRD_A_203	37%	70%	0.149	0.843	0.55	0.61	-	-	0	0	100%	1
5UG4_MRD_A_204	4%	50%	0.307	0.689	0.74	1.18	-	1	1	0	100%	1
7EK9_MRD_A_201	97%	88%	0.06	0.977	0.29	0.38	-	-	0	0	100%	1
4YZA_MRD_A_208	97%	60%	0.056	0.972	0.37	1.15	-	1	0	0	100%	0.91
4MKN_MRD_A_306	97%	67%	0.068	0.98	0.4	0.85	-	-	0	0	100%	0.5
3GZB_MRD_G_156	96%	70%	0.066	0.973	0.43	0.73	-	-	0	0	100%	1
1SWU_MRD_A_1	94%	66%	0.067	0.967	0.41	0.88	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.